Amarin Corp Plcuk (AMRN) Current Deferred Revenue (2013 - 2024)

Amarin Corp Plcuk (AMRN) posted quarterly Current Deferred Revenue of $4.4 million for Q1 2024, down 70.14% YoY from $14.9 million in Q2 2023, and down 8.27% sequentially from $4.8 million in Q4 2023.

Amarin Corp Plcuk (AMRN) Current Deferred Revenue (2013 - 2024) Analysis & Trends

Amarin Corp Plcuk has disclosed Current Deferred Revenue across 11 years of filings, most recently posting $4.4 million for Q1 2024.

  • In Q1 2024, Current Deferred Revenue fell 70.14% year-over-year to $4.4 million; the TTM figure through Mar 2024 stood at $4.4 million (down 70.14% YoY), while the FY2023 annual figure was $4.8 million, down 68.4% from the prior year.
  • Current Deferred Revenue retreated to $4.4 million in Q1 2024, from $4.8 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for AMRN reached as high as $21.8 million in Q1 2020 and fell as low as $4.4 million in Q1 2024.
  • The 5-year median for Current Deferred Revenue is $16.3 million (2022), against an average of $14.5 million.
  • Annual changes were most pronounced in 2020 — Current Deferred Revenue rose 8.15% — and 2024, when it plunged 70.14%.
  • A 5-year view of Current Deferred Revenue shows it stood at $18.6 million in 2020, then slipped by 10.32% to $16.7 million in 2021, then retreated by 8.16% to $15.3 million in 2022, then sank by 68.4% to $4.8 million in 2023, then slipped by 8.27% to $4.4 million in 2024.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $4.4 million, $4.8 million, and $5.0 million for Q1 2024, Q4 2023, and Q3 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 4.45 Mn
Dec 31, 2023 4.85 Mn
Sep 30, 2023 4.97 Mn
Jun 30, 2023 5.36 Mn
Mar 31, 2023 14.90 Mn
Dec 31, 2022 15.35 Mn
Sep 30, 2022 15.70 Mn
Jun 30, 2022 16.01 Mn
Mar 31, 2022 16.34 Mn
Dec 31, 2021 16.71 Mn
Sep 30, 2021 17.13 Mn
Jun 30, 2021 17.97 Mn
Mar 31, 2021 17.97 Mn
Dec 31, 2020 18.63 Mn
Sep 30, 2020 18.91 Mn
Jun 30, 2020 20.21 Mn
Mar 31, 2020 21.81 Mn
Dec 31, 2019 20.85 Mn
Sep 30, 2019 19.58 Mn
Jun 30, 2019 19.74 Mn